"dalfopristin"[nm] - Search Results

Year	Number of Results
1998	9
1999	13
2000	12
2001	6
2002	8
2003	12
2004	4
2005	4
2006	4
2007	3
2008	2
2009	2
2016	1
2018	1
2020	1
2024	0

1

Blondeau JM, Sanche SE. Blondeau JM, et al. Expert Opin Pharmacother. 2002 Sep;3(9):1341-64. doi: 10.1517/14656566.3.9.1341. Expert Opin Pharmacother. 2002. PMID: 12186626 Review.

2

Role of quinupristin/dalfopristin in the treatment of Gram-positive nosocomial infections in haematological or oncological patients.

Klastersky J. Klastersky J. Cancer Treat Rev. 2003 Oct;29(5):431-40. doi: 10.1016/s0305-7372(03)00069-0. Cancer Treat Rev. 2003. PMID: 12972361 Review.

3

Quinupristin/dalfopristin-induced Sweet's syndrome.

Choi HS, Kim HJ, Lee TH, Lee SH, Lee TW, Ihm CG, Kim MJ. Choi HS, et al. Korean J Intern Med. 2003 Sep;18(3):187-90. doi: 10.3904/kjim.2003.18.3.187. Korean J Intern Med. 2003. PMID: 14619389 Free PMC article.

4

Gram-positive infections: pharmacy issues and strategy for quinupristin/dalfopristin.

Rotschafer JC, Wright DH, Brown GH. Rotschafer JC, et al. Diagn Microbiol Infect Dis. 1999 Feb;33(2):95-9. doi: 10.1016/s0732-8893(98)00109-6. Diagn Microbiol Infect Dis. 1999. PMID: 10091032 Review.

5

[Quinupristin/dalfopristin].

Escolar M, Azanza JR, Cárdenas E, Muñoz MJ. Escolar M, et al. Rev Med Univ Navarra. 2001 Oct-Dec;45(4):43-54. Rev Med Univ Navarra. 2001. PMID: 11985218 Review. Spanish. No abstract available.

6

Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.

Lundstrom TS, Sobel JD. Lundstrom TS, et al. Infect Dis Clin North Am. 2000 Jun;14(2):463-74. doi: 10.1016/s0891-5520(05)70258-0. Infect Dis Clin North Am. 2000. PMID: 10829266 Review.

7

Quinupristin-dalfopristin is active against Toxoplasma gondii.

Khan AA, Slifer TR, Araujo FG, Remington JS. Khan AA, et al. Antimicrob Agents Chemother. 1999 Aug;43(8):2043-5. doi: 10.1128/AAC.43.8.2043. Antimicrob Agents Chemother. 1999. PMID: 10428933 Free PMC article.

8

Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.

Pasquaroli S, Citterio B, Mangiaterra G, Biavasco F, Vignaroli C. Pasquaroli S, et al. J Antimicrob Chemother. 2018 Dec 1;73(12):3526-3529. doi: 10.1093/jac/dky338. J Antimicrob Chemother. 2018. PMID: 30169641 No abstract available.

9

Antimicrobial activity of quinupristin/dalfopristin, a new injectable streptogramin with a wide Gram-positive spectrum.

Speciale A, La Ferla K, Caccamo F, Nicoletti G. Speciale A, et al. Int J Antimicrob Agents. 1999 Sep;13(1):21-8. doi: 10.1016/s0924-8579(99)00092-8. Int J Antimicrob Agents. 1999. PMID: 10563401

10

[Other antimicrobial agents (linezolid, quinupristin/dalfopristin, glycylcycline etc)].

Miyazaki S. Miyazaki S. Nihon Rinsho. 2003 Mar;61 Suppl 3:241-7. Nihon Rinsho. 2003. PMID: 12717978 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year